HOME >> BIOLOGY >> NEWS
First target for childhood malaria vaccine

The discovery of a malaria parasite protein that is associated with the severe childhood form of the disease could save the lives of many thousands of children in sub-Saharan Africa. Anja Jensen and colleagues, reporting in The Journal of Experimental Medicine, suggest that this protein could form the basis of a new vaccine against severe malaria.

The malaria-causing parasite Plasmodium falciparum, which is transmitted by mosquito bite, replicates in human red blood cells, which then burst causing life-threatening fever. Infected red blood cells display parasite proteins on their surface that help the parasite to survive in their human host and cause disease complications.

People who have grown up in regions where malaria is endemic usually develop protective antibodies to these parasite proteins, and symptoms in adults are mild compared with the severe disease seen in young children with no previous exposure. Previous work has indicated that the parasites causing severe disease express a set of proteins that are distinct from those produced by parasites that infect adults. But up to this point, no one had identified any of these proteins.

The authors developed a new method to compare for the first time the proteins that are expressed by two types of P. falciparum that cause severe childhood malaria and less severe adult infection, respectively. They identified one protein that is expressed on the surface of red blood cells during severe childhood malaria but not during adult infections. This protein causes infected red blood cells to stick inside blood vessels, preventing their removal in the spleen.

The study also found that this protein, unlike similar malaria proteins studied, does not vary between malaria parasites from East and West Africa, making it an ideal candidate for a universal vaccine to boost immunity to severe malaria in young children.


'"/>

Contact: Lynette Henry
henryn@rockefeller.edu
212-327-8575
Journal of Experimental Medicine
3-May-2004


Page: 1

Related biology news :

1. First glimpse of DNA binding to viral enzyme
2. First clinical study of new pediatric croup vaccine shows safety, tolerability in adults
3. 2nd media alert First Scientific Conference on Childhood Leukaemia
4. First International Scientific Conference on Childhood Leukaemia
5. First ever standards linking climate change, biodiversity and poverty seek global peer review
6. First genetic comparison of purebred domestic dogs produces surprises
7. First time in the U.S.: Saint Louis University tests third-generation vaccine against smallpox
8. First study of resveratrol dietary supplement finds effect on breast and prostate cancers unlikely
9. First flavors form a lasting impression
10. STN International launches Derwent World Patents Index First View
11. First DFG research conference in the USA

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/16/2017)... 16, 2017  Veratad Technologies, LLC ( www.veratad.com ), ... and identity verification solutions, announced today they will participate ... May 15 thru May 17, 2017, in ... Trade Center. Identity impacts the lives ... today,s quickly evolving digital world, defining identity is critical ...
(Date:4/19/2017)... 2017 The global military biometrics ... marked by the presence of several large global players. ... five major players - 3M Cogent, NEC Corporation, M2SYS ... nearly 61% of the global military biometric market in ... global military biometrics market boast global presence, which has ...
(Date:4/13/2017)... According to a new market research report "Consumer IAM Market by ... Service, Authentication Type, Deployment Mode, Vertical, and Region - Global Forecast to ... USD 14.30 Billion in 2017 to USD 31.75 Billion by 2022, at ... ... MarketsandMarkets Logo ...
Breaking Biology News(10 mins):
(Date:10/12/2017)... ... October 12, 2017 , ... AMRI, a global ... industries to improve patient outcomes and quality of life, will now be offering ... being attributed to new regulatory requirements for all new drug products, including the ...
(Date:10/11/2017)... ... October 11, 2017 , ... At ... Purple announced Dr. Suneel I. Sheikh, the co-founder, CEO and chief research scientist ... has been selected for membership in ARCS Alumni Hall of Fame . ...
(Date:10/11/2017)... ... ... is a basic first aid supply for any work environment, but most personal eye wash ... if a dangerous substance enters both eyes? It’s one less decision, and likely quicker response ... piece. , “Whether its dirt and debris, or an acid or alkali, getting anything in ...
(Date:10/11/2017)... Md. (PRWEB) , ... October 11, 2017 , ... ... digital pathology, announced today it will be hosting a Webinar titled, “Pathology is ... Advanced Pathology Associates , on digital pathology adoption best practices and how Proscia ...
Breaking Biology Technology:
Cached News: